The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT

about

The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT

Item

http://www.wikidata.org/entity/Q35848802

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The ThRombolysis in UnconTroll ...... roke patients eligible for IVT

@ast

The ThRombolysis in UnconTroll ...... roke patients eligible for IVT

@en

type

Item

label

The ThRombolysis in UnconTroll ...... roke patients eligible for IVT

@ast

The ThRombolysis in UnconTroll ...... roke patients eligible for IVT

@en

prefLabel

The ThRombolysis in UnconTroll ...... roke patients eligible for IVT

@ast

The ThRombolysis in UnconTroll ...... roke patients eligible for IVT

@en

P1476

The ThRombolysis in UnconTroll ...... roke patients eligible for IVT

@en

P2093

A Algra

http://www.w3.org/2001/XMLSchema#string

D W J Dippel

http://www.w3.org/2001/XMLSchema#string

H B van der Worp

http://www.w3.org/2001/XMLSchema#string

L J Kappelle

http://www.w3.org/2001/XMLSchema#string

M J Wermer

http://www.w3.org/2001/XMLSchema#string

N D Kruyt

http://www.w3.org/2001/XMLSchema#string

P J Nederkoorn

http://www.w3.org/2001/XMLSchema#string

R J van Oostenbrugge

http://www.w3.org/2001/XMLSchema#string

T P Zonneveld

http://www.w3.org/2001/XMLSchema#string

TRUTH investigators

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials.

Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study.

Antihypertensive treatment prolongs tissue plasminogen activator door-to-treatment time: secondary analysis of the INSTINCT trial

Sample size calculations for ordered categorical data.

Treatment effects for which shift or binary analyses are advantageous in acute stroke trials.

Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke.

P2888

s12883-015-0493-z

P304

241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12883-015-0493-Z

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284563380

http://www.w3.org/2001/XMLSchema#string

P6179

1018132950

http://www.w3.org/2001/XMLSchema#string

P698

26596237

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

P932

4657238

http://www.w3.org/2001/XMLSchema#string